RVPH REVIVA PHARMACEUTICALS HOLD...

Nasdaq revivapharma.com


$ 0.61 $ 0.00 (0 %)    

Monday, 03-Nov-2025 08:41:54 EST
QQQ $ 633.64 $ 0.00 (0 %)
DIA $ 475.51 $ 0.00 (0 %)
SPY $ 684.34 $ 0.00 (0 %)
TLT $ 89.71 $ 0.00 (0 %)
GLD $ 369.46 $ 0.00 (0 %)
$ 0.5997
$ 0.61
$ 0.60 x 200
$ 0.62 x 1,680
-- - --
$ 0.25 - $ 4.28
3,765,321
na
40.78M
$ 0.22
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 04-02-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 04-15-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-30-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-15-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 05-17-2021 03-31-2021 10-Q
19 03-22-2021 12-31-2020 10-K
20 01-14-2021 11-30-2020 10-Q
21 10-14-2020 08-31-2020 10-Q
22 07-07-2020 05-31-2020 10-Q
23 05-04-2020 02-29-2020 10-K
24 01-10-2020 11-30-2019 10-Q
25 10-08-2019 08-31-2019 10-Q
26 07-03-2019 05-31-2019 10-Q
27 05-22-2019 02-28-2019 10-K
28 01-09-2019 11-30-2018 10-Q
29 10-11-2018 08-31-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 d-boral-capital-maintains-buy-on-reviva-pharmaceuticals-maintains-2-price-target

D. Boral Capital analyst Jason Kolbert maintains Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and maintains $2 price target.

 hc-wainwright--co-maintains-buy-on-reviva-pharmaceuticals-lowers-price-target-to-4

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and lowers the ...

 this-vse-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 chardan-capital-initiates-coverage-on-reviva-pharmaceuticals-with-buy-rating-announces-price-target-of-2

Chardan Capital analyst Rudy Li initiates coverage on Reviva Pharmaceuticals (NASDAQ: RVPH) with a Buy rating and announces ...

 d-boral-capital-maintains-buy-on-reviva-pharmaceuticals-lowers-price-target-to-2

D. Boral Capital analyst Jason Kolbert maintains Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and lowers the price target...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION